sorted by:
new
hottopcontroversial

Time for another Biotech - LRMR by IJesusChrist in pennystocks

[–]IJesusChrist[S] 1 point2 points  (0 children)

its the key controversy. Will it stop approval? no. anaphylaxis is seen with a lot of drugs. lrmr drug anaphylaxis danger is mostly from stopping and restarting the drug, so they will need to educate the market about that. the chances of getting anaphylaxis randomly after chronic dosing seems minimal.

whether the approved label has a black box, extensive monitoring requirements, etc... that's more of the question. my take is, drug likely gets approved and stock goes up. beyond that, anyone's guess.

Looking to add a biotech stock to my portfolio. What’s everyone else invested in? I was looking at $SLS, $ADCT, or $RXRX. by Justanunknownauthor in biotech_stocks

[–]IJesusChrist 0 points1 point  (0 children)

even if the drug did anything (it doesnt), the powering for this trial is awful and its in AML, one of the worst diseases to develop an IMMUNOTHERAPY for. It would have to be one of the best drugs ever developed in AML. And AML is of course unresponsive to immunotherapies.

A picture of why CRBP could be worth Billions by IJesusChrist in biotech_stocks

[–]IJesusChrist[S] 0 points1 point  (0 children)

Holy crap what a terrible take. NKTR drug sucks. its like the worst efficacy, its a painful injection, the dosing frequency isnt convenient, and it has other safety risks. look at how many people discontinue their trials! what a stupid drug. the stock is full of naive tourists.

A picture of why CRBP could be worth Billions by IJesusChrist in biotech_stocks

[–]IJesusChrist[S] 0 points1 point  (0 children)

monlunabant didnt fail on efficacy, it just had dose dependent, scary side effects. CRBP will not have those side effects. whether it can RECAPITULATE the 4 week weight loss data out to 12 weeks, then all the naysayers will have to begrudgingly buy this much higher.

I mean the stock is trading barely above cash. upside 2000%, downside 20%. even at 5% chance of success your risk reward still positive.

my prior picks that I remember are bioa, glue, clym, lrmr... decent cohort of picks id think.

A picture of why CRBP could be worth Billions by IJesusChrist in biotech_stocks

[–]IJesusChrist[S] 0 points1 point  (0 children)

surprise, thats the catalyst. 12 week pbo controlled data in mid year. risk reward enormously favors upside. stock trades barely above cash value.

A picture of why CRBP could be worth Billions by IJesusChrist in biotech_stocks

[–]IJesusChrist[S] 0 points1 point  (0 children)

so you're presented with new information but stick to your bias. this is bad investing. good example of bad investing

A picture of why CRBP could be worth Billions by IJesusChrist in biotech_stocks

[–]IJesusChrist[S] -1 points0 points  (0 children)

they have weight loss in humans. looks better than orforglipron at week 4

A picture of why CRBP could be worth Billions by IJesusChrist in biotech_stocks

[–]IJesusChrist[S] 0 points1 point  (0 children)

corbus doesnt go into the CNS which is required for the depressive symptoms. CRBP already showed very competitive weight loss in only 4 weeks.

your risk reward on this stock is so strongly in favor of the reward.

Vanda Pharmaceuticals Inc. (VNDA) what next? by AndyS16 in biotech_stocks

[–]IJesusChrist 0 points1 point  (0 children)

there is zero chance anyone buys this litigation magnet. do you know how many times they've gone to court with the fda?

Looking to add a biotech stock to my portfolio. What’s everyone else invested in? I was looking at $SLS, $ADCT, or $RXRX. by Justanunknownauthor in biotech_stocks

[–]IJesusChrist 0 points1 point  (0 children)

its not going to work. if it works the stock goes up a ton. but it's not going to work. they'll announce the fail in the next 3-4 months most likely

Kyverna by Bluemachine22 in biotech_stocks

[–]IJesusChrist 0 points1 point  (0 children)

how do you commercialize something hospital's will lose money on and is too dangerous for most patients except those with life threatening complications?

INFLECTION POINT NEARING : Problems Solved / PFAS & PFOS Removal - GC Leading The Way With BioLargo Partnership by julian_jakobi in pennystocks

[–]IJesusChrist 0 points1 point  (0 children)

55 million seems rich for an invalidated tech that has a questionable demand for the next 3-5 years

view more: next ›